Wanda Health is empowering healthcare providers and payers with early detection of exacerbations in patients with acute, chronic, and specialty diseases, helping them speed interventions, prevent adverse events, and improve patient adherence. The integrated artificial intelligence, remote patient monitoring, and patient adherence features in our platform find potential adverse events up to seven days beforehand warning providers and detail why the patient is having problems. As a result of using Wanda Health, providers are experiencing better outcomes and quality scores, increased care plan adherence, improved patient satisfaction scores, increased revenue, and reduced cost of care for a range of chronic, acute, and specialty diseases and conditions including, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, Hypertension, Diabetes, Wanda Health's usefulness was developed over eight clinical trials at the UCLA hospital system and Cedars Sinai, culminating in seven patents and one patent pending. Based in Seattle, WA, Wanda Health is backed by NetScientific PLC, a London Stock Exchange-listed healthcare, technology, and investment group.